Creo To Present at Biotech Showcase(TM) Digital 2021

San Diego, California--(Newsfile Corp. - January 7, 2021) - Creo, an ingredient company with a proprietary platform for producing natural rare cannabinoids without the cannabis plant, today announced that it is participating in Biotech Showcase 2021 and providing an on-demand company presentation.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Creo will provide an on-demand company presentation at Biotech Showcase 2021.
• Roy Lipski, CEO and Co-founder, will be presenting on the untapped potential of rarer cannabinoids, Creo's fermentation process and an industry on the rise.
• Creo is partnered with biotech industry-leader Genomatica to create a patented fermentation technology platform, allowing for the better production of rare cannabinoids.

Click image above to view full announcement.

About Biotech Showcase
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.

About Creo
Creo is an ingredient company that produces rare and novel cannabinoids using the age-old natural process of fermentation, coupled with cutting-edge technological innovation. Founded in 2016 and based in California, Creo's mission is to enable the creation of cannabinoid products that help people everywhere while doing less harm to the planet. Creo's technology partner and major shareholder is industry-leading biotech firm Genomatica. To learn more, visit www.creoingredients.com.

Contacts:

High10 Media
[email protected]

Source: Creo

Distributed by: Reportable, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/71584